OKYO Pharma Ltd filed a Form 6-K on November 5, 2026, announcing that Chief Executive Officer Robert J. Dempsey is scheduled to present at the Stifel 2026 Healthcare Conference on November 12, 2026.
Key Highlights
- Presenting executive: Robert J. Dempsey, Chief Executive Officer, is scheduled to present at the conference.
- Presentation time: The presentation is scheduled for 9:20 a.m. ET on Thursday, November 12, 2026.
- Conference dates: The Stifel 2026 Healthcare Conference runs November 10-12, 2026.
- Venue: The conference is to be held at the Lotte New York Palace Hotel, New York, NY.
- Investor meetings: OKYO leadership will be available for one-on-one investor meetings throughout the conference; interested investors should contact their Stifel representative, according to the filing.
OKYO Pharma Announces Stifel Conference Participation and CEO Presentation Slot
OKYO Pharma Ltd (NASDAQ:OKYO), a foreign private issuer filing under Commission File Number 001-41386, disclosed on November 5, 2026, that it will participate in the Stifel 2026 Healthcare Conference scheduled for November 10-12, 2026, at the Lotte New York Palace Hotel in New York, NY. The filing was signed by Keeren Shah, Chief Financial Officer, on behalf of the company.
According to the filing, Chief Executive Officer Robert J. Dempsey is scheduled to present at 9:20 a.m. ET on Thursday, November 12, 2026. The company disclosed that, in addition to the formal presentation, OKYO leadership will be available for one-on-one investor meetings throughout the duration of the conference. The filing noted that investors interested in arranging a meeting should contact their Stifel representative.
The filing stated that the accompanying news announcement, furnished as Exhibit 99.1, "shall not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section." The company also noted that the Form 6-K is incorporated by reference into its Registration Statement on Form F-3 (Reg. No. 333-293145).
What Was Disclosed
OKYO Pharma Ltd filed a Form 6-K disclosing its participation in the Stifel 2026 Healthcare Conference, including a scheduled CEO presentation at 9:20 a.m. ET on November 12, 2026, and availability for one-on-one investor meetings at the event.



Please wait processing your request...